Abstract: BACKGROUND: The objective of this prospective study was to assess the efficacy of exercise training as add-on to medical therapy in patients with congenital heart disease associated pulmonary arterial hypertension (CHD-APAH). METHODS: Patients with invasively confirmed CHD-APAH received in-hospital exercise training for 3weeks and continued at home. Efficacy parameters were evaluated at baseline, after 3 and 15weeks. Medical treatment remained unchanged. Worsening events and survival rate were assessed in a follow-up period of 21±14months. RESULTS: Twenty consecutive CHD-APAH patients (16 female, 4 male, mean pulmonary arterial pressure 60±23mmHg) were included. Patients significantly improved the mean distance walked in 6min compared to baseline by 63±47m after 3weeks (p<0.001) and by 67±59m after 15weeks (p=0.001). Quality of life-score (p=0.05), peak oxygen consumption (p=0.002) and maximal workload (p=0.003) improved significantly by exercise training after 15weeks. The 1-and 2-year survival rates were 100%, the transplantation-free survival rate was 100% after 1year and 93% after 2years. CONCLUSION: Exercise training as add-on to medical therapy may be effective in patients with CHD-APAH and improved work capacity, quality of life and further prognostic relevant parameters. It was associated with an excellent long-term survival. Further randomized controlled studies are needed to confirm these results. DOI: https://doi.org/10.1016/j.ijcard.2012.09.036
Structured Abstract
Background: The objective of this prospective study was to assess the efficacy of exercise training as add-on to medical therapy in patients with congenital heart disease associated pulmonary arterial hypertension (CHD-APAH).
Methods:
Patients with invasively confirmed CHD-APAH received in-hospital exercise training for 3 weeks and continued at home. Efficacy parameters were evaluated at baseline, after 3 and 15 weeks. Medical treatment remained unchanged.
Worsening events and survival rate were assessed in a follow-up period of 21±14 months.
Results: Twenty consecutive CHD-APAH patients (16 female, 4 male, mean pulmonary arterial pressure 60±23mmHg) were included. Patients significantly improved the mean distance walked in 6 minutes compared to baseline by 63±47 meters after 3 weeks (p<0.001) and by 67±59 meters after 15 weeks (p=0.001).
Quality of life-score (p=0.05), peak oxygen consumption (p=0.002) and maximal workload (p=0.003) improved significantly by exercise training after 15 weeks. The 1-and 2 year survival rates were 100%, the transplantation-free survival rate was 100% after 1 year and 92% after 2 years.
Conclusion:
Exercise training as add-on to medical therapy may be effective in patients with CHD-APAH and improved work capacity, quality of life and further prognostic relevant parameters. It was associated with an excellent long-term survival. Further randomized controlled studies are needed to confirm these results.
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Introduction
Congenital heart disease-associated pulmonary arterial hypertension (CHD-APAH)
is an important subgroup of associated PAH (APAH) which accounts for approximately 11% of all patients with PAH [1] . In about 0.8-1 of 1000 live births relevant CHD has been diagnosed. Today, in Western countries more than 90% of these children reach adulthood, in some cases with significant pulmonary vascular disease [2] . The prevalence of APAH in CHD in Germany is not known. European registry data suggest a prevalence of APAH in about 4-10% of adult CHD-patients [1, 3, 4] ; up to 25-50% develop an Eisenmenger Syndrome (ES) [5] . Patients with CHD-APAH had identical histological findings as idiopathic PAH (IPAH) [6] and revealed a markedly reduced exercise capacity and quality of life [4, 7] . ES had the worst exercise capacity compared to other forms of CHD-APAH [7] . All-cause mortality risk was more than 2-fold higher for CHD-patients with APAH compared with those without [8] . Estimated 1-, 2-, and 3-year survival rates in CHD-APAH-patients were 97%, 89% and 77%, respectively [9] .
In contrast to IPAH, only few randomized controlled trials on advanced, disease-16 targeted medical therapy have been performed in CHD-APAH including drugs as 17
Bosentan (BREATHE-5 study) [5] and Tadalafil [10] showing significant 18 improvements of pulmonary hemodynamics and exercise tolerance. Positive effects 19 for exercise capacity were also described for sildenafil, epoprostenol and 20 ambrisentan in small, uncontrolled studies [10] [11] [12] [13] . Only few data are available on 21 combination therapies, including 2 to or more PAH-targeted drugs [14] [15] [16] . However, 22 the effect of advanced medical therapy on exercise capacity and quality of life seems 23 to be very limited in this subgroup. Thus, especially patients with CHD-APAH may 24 need additional therapeutic tools addressing their exercise capacity and quality of 25 life. It is unclear whether and to which extend CHD or CHD-APAH-patients should 26 perform sports or exercise training, especially with respect that their hypoxemia 1 usually rapidly deteriorates during exercise. In patients with IPAH and other forms of 2 APAH exercise training as add-on to optimized medical treatment has been shown to 3 increase exercise capacity, quality of life, peak oxygen consumption, WHO-functional 4 class (WHO-FC) in a randomized, controlled study [17] and in single arm studies [18-5 20] and possibly improved clinical outcome [19] . There are only few small 6 uncontrolled studies showing a benefit of exercise training for exercise capacity in 7 CHD-patients without PAH [21] [22] [23] . Except one report with 4 CHD-APAH-patients 8 receiving rehabilitation [24] up to now there is no study focusing on the acute and 9 long-term effect of exercise training in this cohort. The aim of this study was to 10 prospectively assess the effects of exercise training on safety and prognostic 11 relevant factors such as exercise capacity and quality of life in a cohort of patients 12 with severe CHD-APAH and to analyze the 1-and 2 year survival rates. 
Outcome Measures
At baseline, after 3 weeks and 15 weeks efficacy parameters were prospectively evaluated as previously described [17, 19] . 6-minute walking distance (6MWD) was carried out under standardized conditions. Cardiopulmonary exercise testing and stress-Doppler echocardiography were carried out during supine bicycle exercise as described previously [17] . Workload, heart rate, systolic pulmonary artery pressure (sPAP), systolic (RRsys) and diastolic (RRdias) systemic blood pressures, ventilation (VE), oxygen uptake (VO 2 ), oxygen pulse (VO 2 /heart rate), and carbon dioxide output (VCO 2 ) were evaluated continuously. V-slope method was used to detect the anaerobic threshold (AT). We analyzed gas exchange, Borg dyspnea index (with 6
representing no exertion and 20 maximal exertion) [27] 
Exercise Training Program
Exercise training was started in-hospital during 3 weeks in the rehabilitation clinic Königstuhl in Heidelberg as previously described [17, 19] . We performed a program especially developed for the PH-patients with at least 1.5 h exercise training per day (in intervals distributed over the day) consisting of interval bicycle ergometer training at low workloads (10-60 Watt) at 7 days a week. Furthermore walking, dumbbelltraining of single muscle groups using low weights (500-1000g) and respiratory training were performed at 5 days per week. Maximum heart rate during the training corresponded to 60-80% of the heart rate reached during cardiopulmonary exercise testing and was monitored throughout to adjust the training intensity. Those patients who needed oxygen therapy already at rest remained on supplemental oxygen throughout the whole training program. Exercise training was closely supervised by physical therapists, physicians specialized in rehabilitation medicine and PH-experts and was continued at home for 12 weeks using an individualized training manual for at least 30 minutes per day at 5 days a week and a bicycle ergometer. Beside the 
Follow-up Assessment
In 2011 all participating patients were interviewed by telephone or at a control visit in the Thoraxclinic Heidelberg using a half-structured questionnaire. The patients were 
Statistical Methods
The analyses were performed by a statistician (C.F.). Data are given as mean ± standard deviation and as median, 25% and 75% quantiles for more detailed description at baseline. The inner-group comparisons of baseline, weeks 3 and 15 for 6MWD, workload, Borg dyspnea index, parameters of gas exchange, PASP, systemic blood pressure, NT-proBNP and heart rate were conducted by Wilcoxon Greenwood's formula. All treated patients were used for the survival analysis.
Patients with deaths were counted as endpoints, survivors were regarded as censored. .
Assessment of training effects
Exercise training significantly improved mean 6MWD by 63±47 meters after 3 weeks (p<0.001) and by 67±59 meters after 15 weeks (p=0.001) (Figure 1 , Table 2 ). All except two patients improved in 6MWD (Figure 1 ) about more than 5% compared to baseline. The reason for non-response to exercise training in 2 of the 20 patients was in one patient that she could not perform most parts of the rehabilitation program due to a long-lasting respiratory infection. However, she improved in oxygen uptake and quality of life parameters. The other patient had no significant improvement in 6MWD
although she participated in the complete program. After cardiac surgery she had been suffering from a chronic thoracic pain syndrome before she participated in the rehabilitation program.
Exercise training also significantly improved the mean maximal workload during cardiopulmonary exercise testing from baseline to 3 weeks (p<0.012) and to 15 weeks (p<0.003, Table 2 ). Mean peak oxygen uptake (peak VO 2 , Figure 2 ), as well as peak VO 2 /kg per kg body weight increased in trend after 3 weeks (p=0.066 and p=0.063) and significantly after 15 weeks (p=0.002 and p=0.008, respectively, table 2). Mean maximal workload during cardiopulmonary exercise testing increased significantly after 3 and 15 weeks whereas Borg scales remained unchanged ( Table   2 , Figure 3 ).
SF-36 quality of life parameters were significantly impaired compared to an assessment of German standard population (Figure 4 ). Scores did not significantly improve by exercise training except in one subscale "bodily pain" with borderline significant improvement (p=0.05, Figure 4 ). Although in 5 patients WHO-FC has improved from III to II, the change in WHO-FC compared to baseline after 3 and 15 weeks was not significant, possibly due to the small sample size (p=0.157). Mean NTproBNP serum-levels slightly decreased after 3 weeks of exercise training and significantly increased after 15 weeks (Table 2 ).
Mean oxygen saturation was reduced at rest (93±5%), decreased during cardiopulmonay exercise test (84±10%), and remained unchanged during 3 and 15 weeks of exercise training ( Table 2 ). The other parameters as mean systolic and diastolic systemic blood pressures and oxygen pulse remained unchanged.
Missing values, results of imputation role
Five patients (25%) did not attend the visit after 15 weeks (all referred from other PHcenters than Heidelberg) mainly due to the long travel distance, but were reached during the follow-up assessment after 22±14 months. Results remained significant 
Worsening events during follow-up and survival
Follow-up data were obtained after a mean period of 21±14 months ( Figure 5 ).
The 1-and 2-years-overall-survival rate was 100%. After 3 years 95% of our patients were still alive. One patient, aged 23 years, died due to right heart decompensation in a severe acute respiratory infection 2.5 years after rehabilitation. A female 65-years old patient received double-lung transplantation 14 months after exercise training due to disease progression. After transplantation her clinical status rapidly improved. Therefore, transplant-free survival rate after 1 year was 100%, after 2 years 93%. Overall during the follow-up period 12 worsening events were noticed: 1 patient died, 1 lung transplantation, 6 patients required in-hospital treatment (because of pneumonia, hysterectomy, arrhythmia and orthopedic problems). In 1 patient an additional PAH-targeted drug was started due to clinical worsening. In 3 patients WHO-FC had worsened from II to III.
In 18 of the 20 patients information on the exercise training program at home could be obtained. All reported to continue at least some parts of the exercise training program, 74% had continued with walking and dumbbell-training, 68% bicycle ergometer training and 58% respiratory training. Two patients performed additional outdoor bicycle training. Sixty-five percent of patients reported to practice exercise training at least 3 days per week, 50% almost every day.
Adverse events and non-responders
During the 3-weeks in-hospital training 4 patients had adverse events and suffered from respiratory infections; 2 patients received an antibiotic therapy. Three of the 4 patients were able to continue the training program after one or two weeks. In one patient the respiratory infection was long-lasting, so that she could not perform effective exercise training over several weeks. None of the patients had signs of months. However, these data must be confirmed in further randomized, controlled studies.
Assessment of efficacy parameters and setting of exercise training in CHD
The results of this study are in line with previous studies of exercise training in patients with other forms of PH/PAH [17] [18] [19] [20] . These studies showed similar effects in patients with various forms of PH and right heart insufficiency in a randomized controlled [17] and in a single-arm, non-controlled design [18] [19] [20] . However, in these studies only few patients with CHD-APAH have been included [17, 19, 20] . Thus, there are almost no previous data on the effect of exercise training in patients with CHD-APAH. The promising results of this study suggest that in experienced hands exercise training may be an important add-on therapy for these patients especially in regard of their impaired exercise capacity and peak VO 2 . The effects of training may vary between different programs and settings, the results of our study suggest that it can improve clinically relevant parameters. However, an in-hospital start of the rehabilitation program has the advantage of a closely supervised setting which might be beneficial especially in patients with CHD-APAH, since they tend to overestimate their exercise capacity [29] and show severe hypoxemia during exercise. A profound understanding of the pathophysiology of the underlying cardiac anomaly on the part of the trainers and the treating physicians is deeply required.
Improvement in 6-Minute walking distance and peak oxygen uptake
It is well established that patients with CHD, especially those developing pulmonary hypertension and ES have limitation of their exercise capacity [30] . Patients with ES had the most impaired exercise capacity compared to other cyanotic patients [7] .
Reduced peak VO 2 and 6MWD were the main predictors of mortality in patients with CHD-APAH [30] . Therefore, improvement of 6MWD and peak VO 2 by exercise training as reached in this study might be of prognostic relevance. In this study we
show for the first time that CHD-APAH patients can improve their peak VO 2 by exercise training although severe hypoxemia occurred in all patients during the program. 
Quality of life parameters
Although patients with CHD are severely affected with reduced exercise capacity especially in psychosocial aspects quality of life parameters seem to be less impaired as in IPAH-patients [29] . This might be due to the fact that CHD-patients live with the disease from childhood on and might be better adapted to exercise limitations [31] . In our study only the SF-36 subscale "bodily pain" improved in trend by exercise training although exercise capacity and peak VO 2 markedly improved. Possibly in this disease general questionnaires such as the SF-36 are not completely appropriate.
Previous studies found that quality of life parameters in ES-patients were mainly reduced in physical scales [7] .
Survival rate
Adults with CHD-APAH seem to have a better survival than those with IPAH [9] . This might be due to a slower progression of CHD-APAH [31] and to an almost normal cardiac output resulting from associating shunts. Hopkins et al. reported a survival rate of 89% at 2 years and 77% at 3 years in patients with CHD-APAH [9] . The development of ES increased mortality about 10-to 12-fold [32] and was estimated by 20.6% in 5 years [4] . Lowe et al. showed in a retrospective cohort study that the diagnosis of P(A)H in CHD increased mortality rate more than 2-fold. Heart failure and arrhythmia occurred 3-fold more often in CHD-APAH than in CHD-patients without P(A)H [8] . Compared to the previous reported survival rates [4, 9, 32] and considering the severely impaired hemodynamic compromise of the patients assessed in this study the documented overall 2-year survival rate of 100% and transplantation-free 2-year survival rate of 93% suggest that exercise training did at least not reduce but rather improve clinical worsening and long-term survival. However, for further assessment of long-term effects further randomized, controlled trials in a larger patient population are needed.
Adverse events and non-responder
Although no severe adverse effects occurred during the in-hospital exercise training program of this study, in our opinion those programs should be closely monitored by PH-experts. Exercise training in CHD-APAH seems to be an effective add-on therapy but it is not completely harmless. During exercise training severe deterioration of oxygen saturation occurred in almost all patients. In addition the severely impaired right heart function needed to be monitored. Especially exercise training in patients with CHD-APAH has to address special needs and pathophysiological circumstances.
Limitations
The results of this prospective study are limited by the small number of patients with CHD-APAH and the lack of randomization. Because of this, there could be a referral bias that patients doing well have been selected. Nevertheless, the study provides a good rationale for future randomized-controlled studies. The effects of exercise training after 15 weeks may be further biased due to the missing values of 25% of patients who did not perform the last follow-up visit. However, the efficacy after 3 weeks exercise and respiratory therapy and the high proportion of patients who continued with the program suggest a positive effect in this cohort. The significant effect and high compliance of exercise training in CHD-APAH-patients might also be due to the closely supervised in-hospital rehabilitation program, which probably cannot be simply translated to an out-patient program. This limits the application of this program in other countries which cannot provide in-hospital rehabilitation care. Peak VO 2 increased continuously in mean change from 831±220 to 902±267 after 3 weeks (n=16) and to 925±264 ml/min after 15 weeks (n=14). Minimum and maximum are indicated. Within a follow-up period of 21±14 months 1 patient died and 1 patient received a lungtransplantation. Thus, the 1-year and 2-year overall survival rate was 100%. The transplantation-free survival after 2 years was 93%. The dashed lines represent the 95 th percentile of the overall-and transplantation-free survival rates. 
